Skip to content
buyWeak

Gimhana Sasanka Dissanayake bought $11k of BDPT

director at BIOADAPTIVES, INC.. 125,000 shares at an average of $0.09, traded Nov 22, 2024, filed Dec 3, 2024.

Conviction score
23
Value
$11k
125,000 shares
Holdings after
125,000
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $11k at market
    0
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +4.5%, 3m +116.2%, 6m +27.3%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BDPTOct 9, 2026 · close 0.00
Since filing Dec 3, 2024: -97.3%SPY +31.8% · excess -129.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001640334-24-001815, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 22, 2024POpen-market purchase
Common
+125,000$0.09$11k125,000Dec 3, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.